Stromal collagen IV expression and risk of breast cancer death in ductal carcinoma in situ
Abundance of stromal collagen IV increases risk of dying in breast cancer after DCIS, and collagen IV can promote cell motility in vitro.
Authors
- Rebecca Wiberg (ORCID: https://orcid.org/0000-0002-2777-8184)
- Gunilla Rask (ORCID: https://orcid.org/0000-0002-0829-896X)
- Johan Svensson (ORCID: https://orcid.org/0000-0002-8601-0159)
- Malin Sund (ORCID: https://orcid.org/0000-0002-7516-9543)
- Ola Billing (ORCID: https://orcid.org/0000-0001-5824-6263)
- Fredrik Wärnberg (ORCID: https://orcid.org/0000-0002-0130-7296)
- Charlotta Wadsten (ORCID: https://orcid.org/0000-0003-0571-7265)
- Malin Jansson (ORCID: https://orcid.org/0000-0003-2624-4671)
Institutions
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- BJC Reports
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1038/s44276-025-00191-w
- Primary Topic
- TGF-β signaling in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Falk Foundation
- Percy Falk Foundation
- Umeå Universitet